Breakthrough treatment trial aims to save kids from deadly e. coli kidney damage
Disease control
Recruiting now
This study is testing whether adding a new antibody treatment called INM004 to standard care helps children recover faster from a serious kidney condition caused by E. coli infection. The trial involves 220 children aged 9 months to 18 years who have developed kidney damage after…
Phase: PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Apr 02, 2026 08:57 UTC